SEARCH

SEARCH BY CITATION

References

  • 1
    Isaacson PG, Chott A, Nakamura S, Müller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: SwerdlowSH, CampoE, HarrisNL, JaffeES, PileriSA, SteinH, ThieleJ, VardimanJW, eds. World Health Organization Classification of tumours of hematopoietic and lymphoid tisues. Lyon: IARC press, 2008. 2147.
  • 2
    Krol AD, Hermans J, Kramer MH, Kluin PM, Kluin-Nelemans HC, Blok P, Heering KJ, Noordijk EM, van Krieken JH. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer 1997; 79: 3907.
  • 3
    Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J, Liersch R, del VF, Clasen H, Hirt C, Breitsprecher R, Schmits R, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 70509.
  • 4
    Morgner A, Schmelz R, Thiede C, Stolte M, Miehlke S. Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol 2007; 13: 355466.
  • 5
    Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, Biondi A, Cavalli F. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338( 12): 80410.
  • 6
    Barth TF, Bentz M, Leithäuser F, Stilgenbauer S, Siebert R, Schlotter M, Schlenk RF, Döhner H, Möller P. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001; 31: 31625.
  • 7
    Barth TF, Döhner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M, Lichter P, Möller P, Bentz M. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998; 91: 432130.
  • 8
    Chan WY, Wong N, Chan AB, Chow JH, Lee JC. Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach. Am J Pathol 1998; 152: 116.
  • 9
    Ott G, Kalla J, Steinhoff A, Rosenwald A, Katzenberger T, Roblick U, Ott MM, Müller-Hermelink HK. Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 1998; 153: 68994.
  • 10
    Hoeve MA, Gisbertz IA, Schouten HC, Schuuring E, Bot FJ, Hermans J, Hopman A, Kluin PM, Arends JW, van Krieken JH. Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 1999; 13: 799807.
  • 11
    Barth TF, Barth CA, Kestler HA, Michl P, Weniger MA, Buchholz M, Möller P, Gress T. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 2007; 211: 30513.
  • 12
    Zentrale Ethikkommission bei der Bundesärztekammer. Mitteilungen: Die (Weiter-)Verwendung von menschlichen Körpermaterialien fu̇r Zwecke medizinischer Forschung. Dtsch Arztebl 2003; 100A: 1632.
  • 13
    van Rijk A, Mason D, Jones M, Cabecadas J, Crespo M, Cigudosa JC, Garcia JF, Leoncini L, Cocco M, Hansmann ML, Mottok A, Copie BC, et al. Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. J Hematop 2008; 1: 11926.
  • 14
    Haralambieva E, Adam P, Ventura R, Katzenberger T, Kalla J, Holler S, Hartmann M, Rosenwald A, Greiner A, Müller-Hermelink HK, Banham AH, Ott G. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 2006; 20: 13003.
  • 15
    Sanchez-Izquierdo D, Siebert R, Harder L, Marugan I, Gozzetti A, Price HP, Gesk S, Hernandez-Rivas JM, Benet I, Sole F, Sonoki T, Le Beau MM, et al. Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia 2001; 15: 147584.
  • 16
    Ye H, Gong L, Liu H, Ruskone-Fourmestraux A, de JD, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut 2006; 55: 1378.
  • 17
    Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, Siebert R. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006; 8: 14151.
  • 18
    Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 2000; 157: 114754.
  • 19
    Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Möller P. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003; 101: 36816.
  • 20
    Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999; 22: 638.
  • 21
    Thome M, Martinon F, Hofmann K, Rubio V, Steiner V, Schneider P, Mattmann C, Tschopp J. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem 1999; 274: 99628.
  • 22
    Chuang SS, Liu H, Martin-Subero JI, Siebert R, Huang WT, Ye H. Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma 10 (BCL10) expression and novel translocation t(1;2)(p22;p12)/immunoglobulin kappa chain-BCL10. J Clin Pathol 2007; 60: 7278.
  • 23
    Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 6528.
  • 24
    Wlodarska I, Veyt E, de PP, Vandenberghe P, Nooijen P, Theate I, Michaux L, Sagaert X, Marynen P, Hagemeijer A, De Wolf-Peeters C. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 2005; 19: 1299305.
  • 25
    Goatly A, Bacon CM, Nakamura S, Ye H, Kim I, Brown PJ, Ruskone-Fourmestraux A, Cervera P, Streubel B, Banham AH, Du MQ. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008; 21: 90211.
  • 26
    Barrans SL, Fenton JA, Banham A, Owen RG, Jack AS. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004; 104: 29335.
  • 27
    Sagaert X, de PP, Libbrecht L, Vanhentenrijk V, Verhoef G, Thomas J, Wlodarska I, De Wolf-Peeters C. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 24907.
  • 28
    Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M, Dewald GW, Kurtin PJ. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 2006; 30: 154653.
  • 29
    Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Banham AH, Ventura R, Matsumoto T, Iida M, Ohji Y, Yao T, Tsuneyoshi M, et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007; 56: 135863.
  • 30
    Vinatzer U, Gollinger M, Mullauer L, Raderer M, Chott A, Streubel B. Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res 2008; 14: 642631.
  • 31
    Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007; 47: 3142.
  • 32
    Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Kerr L, Banham AH, Streubel B, Yao T, Tsuneyoshi M, Savio A, Takeshita M, et al. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res 2008; 14: 300210.
  • 33
    Cogliatti SB, Novak U, Henz S, Schmid U, Möller P, Barth TF. Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol 2006; 134: 294301.
  • 34
    Phan RT, la-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432: 6359.
  • 35
    Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Müller-Hermelink HK, Gascoyne RD, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 2007; 204: 63343.
  • 36
    Ye H, Remstein ED, Bacon CM, Nicholson AG, Dogan A, Du MQ. Chromosomal translocations involving BCL6 in MALT lymphoma. Haematologica 2008; 93: 1456.
  • 37
    Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, Raffeld M. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 1995; 85: 287784.
  • 38
    Chaganti SR, Chen W, Parsa N, Offit K, Louie DC, la-Favera R, Chaganti RS. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes Chromosomes Cancer 1998; 23: 3237.
  • 39
    Tibiletti MG, Martin V, Bernasconi B, Del CB, Pecciarini L, Uccella S, Pruneri G, Ponzoni M, Mazzucchelli L, Martinelli G, Ferreri AJ, Pinotti G, et al. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. Hum Pathol 2009; 40: 64552.
  • 40
    Chen YW, Hu XT, Liang AC, Au WY, So CC, Wong ML, Shen L, Tao Q, Chu KM, Kwong YL, Liang RH, Srivastava G. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. Blood 2006; 108: 237383.
  • 41
    Skinnider BF, Horsman DE, Dupuis B, Gascoyne RD. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 1999; 30: 8038.
  • 42
    Jardin F, Gaulard P, Buchonnet G, Contentin N, Lepretre S, Lenain P, Stamatoullas A, Picquenot JM, Duval C, Parmentier F, Tilly H, Bastard C. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia 2002; 16: 230917.